Global Personalized Therapy Biosimulation Platform Supply, Demand and Key Producers, 2023-2029
The global Personalized Therapy Biosimulation Platform market size is expected to reach $ 3583.9 million by 2029, rising at a market growth of 14.0% CAGR during the forecast period (2023-2029).
Increasing prevalence of malignancies and cancers, rising demand for biologics and biopharmaceuticals, high failure rate of clinical trials and high incidence of drug resistance are the key factors driving the growth of biomimetic personalized therapy market revenue.
Personalized Therapy Biosimulation refers to biosimulating a patient's unique cancer response to therapy prior to treatment and identifying new drug combinations for refractory patients. By utilizing this technology to determine a patient's Therapeutic Response Index, or TRI. TRIs in treatment-naive patients determine whether a patient will respond to standard-of-care treatments. For relapsed or refractory patients, TRIs identify the ideal combination of FDA-approved drugs that patients will respond to.
This report studies the global Personalized Therapy Biosimulation Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Personalized Therapy Biosimulation Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Personalized Therapy Biosimulation Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Personalized Therapy Biosimulation Platform total market, 2018-2029, (USD Million)
Global Personalized Therapy Biosimulation Platform total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Personalized Therapy Biosimulation Platform total market, key domestic companies and share, (USD Million)
Global Personalized Therapy Biosimulation Platform revenue by player and market share 2018-2023, (USD Million)
Global Personalized Therapy Biosimulation Platform total market by Type, CAGR, 2018-2029, (USD Million)
Global Personalized Therapy Biosimulation Platform total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Personalized Therapy Biosimulation Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellworks Group, Certara, Simulation Plus, Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology and Chemical Computing Group ULC(CCG), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Personalized Therapy Biosimulation Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Personalized Therapy Biosimulation Platform Market, By Region:
1. How big is the global Personalized Therapy Biosimulation Platform market?
2. What is the demand of the global Personalized Therapy Biosimulation Platform market?
3. What is the year over year growth of the global Personalized Therapy Biosimulation Platform market?
4. What is the total value of the global Personalized Therapy Biosimulation Platform market?
5. Who are the major players in the global Personalized Therapy Biosimulation Platform market?
6. What are the growth factors driving the market demand?
Increasing prevalence of malignancies and cancers, rising demand for biologics and biopharmaceuticals, high failure rate of clinical trials and high incidence of drug resistance are the key factors driving the growth of biomimetic personalized therapy market revenue.
Personalized Therapy Biosimulation refers to biosimulating a patient's unique cancer response to therapy prior to treatment and identifying new drug combinations for refractory patients. By utilizing this technology to determine a patient's Therapeutic Response Index, or TRI. TRIs in treatment-naive patients determine whether a patient will respond to standard-of-care treatments. For relapsed or refractory patients, TRIs identify the ideal combination of FDA-approved drugs that patients will respond to.
This report studies the global Personalized Therapy Biosimulation Platform demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Personalized Therapy Biosimulation Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Personalized Therapy Biosimulation Platform that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Personalized Therapy Biosimulation Platform total market, 2018-2029, (USD Million)
Global Personalized Therapy Biosimulation Platform total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Personalized Therapy Biosimulation Platform total market, key domestic companies and share, (USD Million)
Global Personalized Therapy Biosimulation Platform revenue by player and market share 2018-2023, (USD Million)
Global Personalized Therapy Biosimulation Platform total market by Type, CAGR, 2018-2029, (USD Million)
Global Personalized Therapy Biosimulation Platform total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Personalized Therapy Biosimulation Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cellworks Group, Certara, Simulation Plus, Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology and Chemical Computing Group ULC(CCG), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Personalized Therapy Biosimulation Platform market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Personalized Therapy Biosimulation Platform Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Pharmacokinetic
- Pharmacoeconomics
- Pharmaceutical and Biotech Companies
- Research Institutions
- Hospital
- Others
- Cellworks Group
- Certara
- Simulation Plus
- Schrodinger
- In Silico Biosciences
- Genedata
- Physiomics
- Insilico Biotechology
- Chemical Computing Group ULC(CCG)
- Evidera
- AnyLogic
- Shanghai Lide
1. How big is the global Personalized Therapy Biosimulation Platform market?
2. What is the demand of the global Personalized Therapy Biosimulation Platform market?
3. What is the year over year growth of the global Personalized Therapy Biosimulation Platform market?
4. What is the total value of the global Personalized Therapy Biosimulation Platform market?
5. Who are the major players in the global Personalized Therapy Biosimulation Platform market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Personalized Therapy Biosimulation Platform Introduction
1.2 World Personalized Therapy Biosimulation Platform Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Personalized Therapy Biosimulation Platform Total Market by Region (by Headquarter Location)
1.3.1 World Personalized Therapy Biosimulation Platform Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.3 China Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.4 Europe Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.5 Japan Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.6 South Korea Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.7 ASEAN Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.8 India Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Personalized Therapy Biosimulation Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Personalized Therapy Biosimulation Platform Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.2 World Personalized Therapy Biosimulation Platform Consumption Value by Region
2.2.1 World Personalized Therapy Biosimulation Platform Consumption Value by Region (2018-2023)
2.2.2 World Personalized Therapy Biosimulation Platform Consumption Value Forecast by Region (2024-2029)
2.3 United States Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.4 China Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.5 Europe Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.6 Japan Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.7 South Korea Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.8 ASEAN Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.9 India Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
3 WORLD PERSONALIZED THERAPY BIOSIMULATION PLATFORM COMPANIES COMPETITIVE ANALYSIS
3.1 World Personalized Therapy Biosimulation Platform Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Personalized Therapy Biosimulation Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Personalized Therapy Biosimulation Platform in 2022
3.2.3 Global Concentration Ratios (CR8) for Personalized Therapy Biosimulation Platform in 2022
3.3 Personalized Therapy Biosimulation Platform Company Evaluation Quadrant
3.4 Personalized Therapy Biosimulation Platform Market: Overall Company Footprint Analysis
3.4.1 Personalized Therapy Biosimulation Platform Market: Region Footprint
3.4.2 Personalized Therapy Biosimulation Platform Market: Company Product Type Footprint
3.4.3 Personalized Therapy Biosimulation Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Personalized Therapy Biosimulation Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Personalized Therapy Biosimulation Platform Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Personalized Therapy Biosimulation Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Personalized Therapy Biosimulation Platform Consumption Value Comparison
4.2.1 United States VS China: Personalized Therapy Biosimulation Platform Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Personalized Therapy Biosimulation Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Personalized Therapy Biosimulation Platform Companies and Market Share, 2018-2023
4.3.1 United States Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023)
4.4 China Based Companies Personalized Therapy Biosimulation Platform Revenue and Market Share, 2018-2023
4.4.1 China Based Personalized Therapy Biosimulation Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023)
4.5 Rest of World Based Personalized Therapy Biosimulation Platform Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Personalized Therapy Biosimulation Platform Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pharmacokinetic
5.2.2 Pharmacoeconomics
5.3 Market Segment by Type
5.3.1 World Personalized Therapy Biosimulation Platform Market Size by Type (2018-2023)
5.3.2 World Personalized Therapy Biosimulation Platform Market Size by Type (2024-2029)
5.3.3 World Personalized Therapy Biosimulation Platform Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Personalized Therapy Biosimulation Platform Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical and Biotech Companies
6.2.2 Research Institutions
6.2.3 Hospital
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Personalized Therapy Biosimulation Platform Market Size by Application (2018-2023)
6.3.2 World Personalized Therapy Biosimulation Platform Market Size by Application (2024-2029)
6.3.3 World Personalized Therapy Biosimulation Platform Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cellworks Group
7.1.1 Cellworks Group Details
7.1.2 Cellworks Group Major Business
7.1.3 Cellworks Group Personalized Therapy Biosimulation Platform Product and Services
7.1.4 Cellworks Group Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Cellworks Group Recent Developments/Updates
7.1.6 Cellworks Group Competitive Strengths & Weaknesses
7.2 Certara
7.2.1 Certara Details
7.2.2 Certara Major Business
7.2.3 Certara Personalized Therapy Biosimulation Platform Product and Services
7.2.4 Certara Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Certara Recent Developments/Updates
7.2.6 Certara Competitive Strengths & Weaknesses
7.3 Simulation Plus
7.3.1 Simulation Plus Details
7.3.2 Simulation Plus Major Business
7.3.3 Simulation Plus Personalized Therapy Biosimulation Platform Product and Services
7.3.4 Simulation Plus Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Simulation Plus Recent Developments/Updates
7.3.6 Simulation Plus Competitive Strengths & Weaknesses
7.4 Schrodinger
7.4.1 Schrodinger Details
7.4.2 Schrodinger Major Business
7.4.3 Schrodinger Personalized Therapy Biosimulation Platform Product and Services
7.4.4 Schrodinger Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Schrodinger Recent Developments/Updates
7.4.6 Schrodinger Competitive Strengths & Weaknesses
7.5 In Silico Biosciences
7.5.1 In Silico Biosciences Details
7.5.2 In Silico Biosciences Major Business
7.5.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Product and Services
7.5.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 In Silico Biosciences Recent Developments/Updates
7.5.6 In Silico Biosciences Competitive Strengths & Weaknesses
7.6 Genedata
7.6.1 Genedata Details
7.6.2 Genedata Major Business
7.6.3 Genedata Personalized Therapy Biosimulation Platform Product and Services
7.6.4 Genedata Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Genedata Recent Developments/Updates
7.6.6 Genedata Competitive Strengths & Weaknesses
7.7 Physiomics
7.7.1 Physiomics Details
7.7.2 Physiomics Major Business
7.7.3 Physiomics Personalized Therapy Biosimulation Platform Product and Services
7.7.4 Physiomics Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Physiomics Recent Developments/Updates
7.7.6 Physiomics Competitive Strengths & Weaknesses
7.8 Insilico Biotechology
7.8.1 Insilico Biotechology Details
7.8.2 Insilico Biotechology Major Business
7.8.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Product and Services
7.8.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Insilico Biotechology Recent Developments/Updates
7.8.6 Insilico Biotechology Competitive Strengths & Weaknesses
7.9 Chemical Computing Group ULC(CCG)
7.9.1 Chemical Computing Group ULC(CCG) Details
7.9.2 Chemical Computing Group ULC(CCG) Major Business
7.9.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product and Services
7.9.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Chemical Computing Group ULC(CCG) Recent Developments/Updates
7.9.6 Chemical Computing Group ULC(CCG) Competitive Strengths & Weaknesses
7.10 Evidera
7.10.1 Evidera Details
7.10.2 Evidera Major Business
7.10.3 Evidera Personalized Therapy Biosimulation Platform Product and Services
7.10.4 Evidera Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Evidera Recent Developments/Updates
7.10.6 Evidera Competitive Strengths & Weaknesses
7.11 AnyLogic
7.11.1 AnyLogic Details
7.11.2 AnyLogic Major Business
7.11.3 AnyLogic Personalized Therapy Biosimulation Platform Product and Services
7.11.4 AnyLogic Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AnyLogic Recent Developments/Updates
7.11.6 AnyLogic Competitive Strengths & Weaknesses
7.12 Shanghai Lide
7.12.1 Shanghai Lide Details
7.12.2 Shanghai Lide Major Business
7.12.3 Shanghai Lide Personalized Therapy Biosimulation Platform Product and Services
7.12.4 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Shanghai Lide Recent Developments/Updates
7.12.6 Shanghai Lide Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Personalized Therapy Biosimulation Platform Industry Chain
8.2 Personalized Therapy Biosimulation Platform Upstream Analysis
8.3 Personalized Therapy Biosimulation Platform Midstream Analysis
8.4 Personalized Therapy Biosimulation Platform Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Personalized Therapy Biosimulation Platform Introduction
1.2 World Personalized Therapy Biosimulation Platform Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Personalized Therapy Biosimulation Platform Total Market by Region (by Headquarter Location)
1.3.1 World Personalized Therapy Biosimulation Platform Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.3 China Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.4 Europe Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.5 Japan Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.6 South Korea Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.7 ASEAN Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.3.8 India Personalized Therapy Biosimulation Platform Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Personalized Therapy Biosimulation Platform Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Personalized Therapy Biosimulation Platform Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.2 World Personalized Therapy Biosimulation Platform Consumption Value by Region
2.2.1 World Personalized Therapy Biosimulation Platform Consumption Value by Region (2018-2023)
2.2.2 World Personalized Therapy Biosimulation Platform Consumption Value Forecast by Region (2024-2029)
2.3 United States Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.4 China Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.5 Europe Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.6 Japan Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.7 South Korea Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.8 ASEAN Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
2.9 India Personalized Therapy Biosimulation Platform Consumption Value (2018-2029)
3 WORLD PERSONALIZED THERAPY BIOSIMULATION PLATFORM COMPANIES COMPETITIVE ANALYSIS
3.1 World Personalized Therapy Biosimulation Platform Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Personalized Therapy Biosimulation Platform Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Personalized Therapy Biosimulation Platform in 2022
3.2.3 Global Concentration Ratios (CR8) for Personalized Therapy Biosimulation Platform in 2022
3.3 Personalized Therapy Biosimulation Platform Company Evaluation Quadrant
3.4 Personalized Therapy Biosimulation Platform Market: Overall Company Footprint Analysis
3.4.1 Personalized Therapy Biosimulation Platform Market: Region Footprint
3.4.2 Personalized Therapy Biosimulation Platform Market: Company Product Type Footprint
3.4.3 Personalized Therapy Biosimulation Platform Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Personalized Therapy Biosimulation Platform Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Personalized Therapy Biosimulation Platform Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Personalized Therapy Biosimulation Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Personalized Therapy Biosimulation Platform Consumption Value Comparison
4.2.1 United States VS China: Personalized Therapy Biosimulation Platform Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Personalized Therapy Biosimulation Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Personalized Therapy Biosimulation Platform Companies and Market Share, 2018-2023
4.3.1 United States Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023)
4.4 China Based Companies Personalized Therapy Biosimulation Platform Revenue and Market Share, 2018-2023
4.4.1 China Based Personalized Therapy Biosimulation Platform Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023)
4.5 Rest of World Based Personalized Therapy Biosimulation Platform Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Personalized Therapy Biosimulation Platform Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Pharmacokinetic
5.2.2 Pharmacoeconomics
5.3 Market Segment by Type
5.3.1 World Personalized Therapy Biosimulation Platform Market Size by Type (2018-2023)
5.3.2 World Personalized Therapy Biosimulation Platform Market Size by Type (2024-2029)
5.3.3 World Personalized Therapy Biosimulation Platform Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Personalized Therapy Biosimulation Platform Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical and Biotech Companies
6.2.2 Research Institutions
6.2.3 Hospital
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Personalized Therapy Biosimulation Platform Market Size by Application (2018-2023)
6.3.2 World Personalized Therapy Biosimulation Platform Market Size by Application (2024-2029)
6.3.3 World Personalized Therapy Biosimulation Platform Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cellworks Group
7.1.1 Cellworks Group Details
7.1.2 Cellworks Group Major Business
7.1.3 Cellworks Group Personalized Therapy Biosimulation Platform Product and Services
7.1.4 Cellworks Group Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Cellworks Group Recent Developments/Updates
7.1.6 Cellworks Group Competitive Strengths & Weaknesses
7.2 Certara
7.2.1 Certara Details
7.2.2 Certara Major Business
7.2.3 Certara Personalized Therapy Biosimulation Platform Product and Services
7.2.4 Certara Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Certara Recent Developments/Updates
7.2.6 Certara Competitive Strengths & Weaknesses
7.3 Simulation Plus
7.3.1 Simulation Plus Details
7.3.2 Simulation Plus Major Business
7.3.3 Simulation Plus Personalized Therapy Biosimulation Platform Product and Services
7.3.4 Simulation Plus Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Simulation Plus Recent Developments/Updates
7.3.6 Simulation Plus Competitive Strengths & Weaknesses
7.4 Schrodinger
7.4.1 Schrodinger Details
7.4.2 Schrodinger Major Business
7.4.3 Schrodinger Personalized Therapy Biosimulation Platform Product and Services
7.4.4 Schrodinger Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Schrodinger Recent Developments/Updates
7.4.6 Schrodinger Competitive Strengths & Weaknesses
7.5 In Silico Biosciences
7.5.1 In Silico Biosciences Details
7.5.2 In Silico Biosciences Major Business
7.5.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Product and Services
7.5.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 In Silico Biosciences Recent Developments/Updates
7.5.6 In Silico Biosciences Competitive Strengths & Weaknesses
7.6 Genedata
7.6.1 Genedata Details
7.6.2 Genedata Major Business
7.6.3 Genedata Personalized Therapy Biosimulation Platform Product and Services
7.6.4 Genedata Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Genedata Recent Developments/Updates
7.6.6 Genedata Competitive Strengths & Weaknesses
7.7 Physiomics
7.7.1 Physiomics Details
7.7.2 Physiomics Major Business
7.7.3 Physiomics Personalized Therapy Biosimulation Platform Product and Services
7.7.4 Physiomics Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Physiomics Recent Developments/Updates
7.7.6 Physiomics Competitive Strengths & Weaknesses
7.8 Insilico Biotechology
7.8.1 Insilico Biotechology Details
7.8.2 Insilico Biotechology Major Business
7.8.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Product and Services
7.8.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Insilico Biotechology Recent Developments/Updates
7.8.6 Insilico Biotechology Competitive Strengths & Weaknesses
7.9 Chemical Computing Group ULC(CCG)
7.9.1 Chemical Computing Group ULC(CCG) Details
7.9.2 Chemical Computing Group ULC(CCG) Major Business
7.9.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product and Services
7.9.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Chemical Computing Group ULC(CCG) Recent Developments/Updates
7.9.6 Chemical Computing Group ULC(CCG) Competitive Strengths & Weaknesses
7.10 Evidera
7.10.1 Evidera Details
7.10.2 Evidera Major Business
7.10.3 Evidera Personalized Therapy Biosimulation Platform Product and Services
7.10.4 Evidera Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Evidera Recent Developments/Updates
7.10.6 Evidera Competitive Strengths & Weaknesses
7.11 AnyLogic
7.11.1 AnyLogic Details
7.11.2 AnyLogic Major Business
7.11.3 AnyLogic Personalized Therapy Biosimulation Platform Product and Services
7.11.4 AnyLogic Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 AnyLogic Recent Developments/Updates
7.11.6 AnyLogic Competitive Strengths & Weaknesses
7.12 Shanghai Lide
7.12.1 Shanghai Lide Details
7.12.2 Shanghai Lide Major Business
7.12.3 Shanghai Lide Personalized Therapy Biosimulation Platform Product and Services
7.12.4 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Shanghai Lide Recent Developments/Updates
7.12.6 Shanghai Lide Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Personalized Therapy Biosimulation Platform Industry Chain
8.2 Personalized Therapy Biosimulation Platform Upstream Analysis
8.3 Personalized Therapy Biosimulation Platform Midstream Analysis
8.4 Personalized Therapy Biosimulation Platform Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Personalized Therapy Biosimulation Platform Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Personalized Therapy Biosimulation Platform Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Personalized Therapy Biosimulation Platform Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Personalized Therapy Biosimulation Platform Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Personalized Therapy Biosimulation Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Personalized Therapy Biosimulation Platform Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Personalized Therapy Biosimulation Platform Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Personalized Therapy Biosimulation Platform Players in 2022
Table 12. World Personalized Therapy Biosimulation Platform Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Personalized Therapy Biosimulation Platform Company Evaluation Quadrant
Table 14. Head Office of Key Personalized Therapy Biosimulation Platform Player
Table 15. Personalized Therapy Biosimulation Platform Market: Company Product Type Footprint
Table 16. Personalized Therapy Biosimulation Platform Market: Company Product Application Footprint
Table 17. Personalized Therapy Biosimulation Platform Mergers & Acquisitions Activity
Table 18. United States VS China Personalized Therapy Biosimulation Platform Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Personalized Therapy Biosimulation Platform Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Personalized Therapy Biosimulation Platform Revenue Market Share (2018-2023)
Table 23. China Based Personalized Therapy Biosimulation Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Personalized Therapy Biosimulation Platform Revenue Market Share (2018-2023)
Table 26. Rest of World Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Personalized Therapy Biosimulation Platform Revenue Market Share (2018-2023)
Table 29. World Personalized Therapy Biosimulation Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Personalized Therapy Biosimulation Platform Market Size by Type (2018-2023) & (USD Million)
Table 31. World Personalized Therapy Biosimulation Platform Market Size by Type (2024-2029) & (USD Million)
Table 32. World Personalized Therapy Biosimulation Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Personalized Therapy Biosimulation Platform Market Size by Application (2018-2023) & (USD Million)
Table 34. World Personalized Therapy Biosimulation Platform Market Size by Application (2024-2029) & (USD Million)
Table 35. Cellworks Group Basic Information, Area Served and Competitors
Table 36. Cellworks Group Major Business
Table 37. Cellworks Group Personalized Therapy Biosimulation Platform Product and Services
Table 38. Cellworks Group Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cellworks Group Recent Developments/Updates
Table 40. Cellworks Group Competitive Strengths & Weaknesses
Table 41. Certara Basic Information, Area Served and Competitors
Table 42. Certara Major Business
Table 43. Certara Personalized Therapy Biosimulation Platform Product and Services
Table 44. Certara Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Certara Recent Developments/Updates
Table 46. Certara Competitive Strengths & Weaknesses
Table 47. Simulation Plus Basic Information, Area Served and Competitors
Table 48. Simulation Plus Major Business
Table 49. Simulation Plus Personalized Therapy Biosimulation Platform Product and Services
Table 50. Simulation Plus Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Simulation Plus Recent Developments/Updates
Table 52. Simulation Plus Competitive Strengths & Weaknesses
Table 53. Schrodinger Basic Information, Area Served and Competitors
Table 54. Schrodinger Major Business
Table 55. Schrodinger Personalized Therapy Biosimulation Platform Product and Services
Table 56. Schrodinger Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Schrodinger Recent Developments/Updates
Table 58. Schrodinger Competitive Strengths & Weaknesses
Table 59. In Silico Biosciences Basic Information, Area Served and Competitors
Table 60. In Silico Biosciences Major Business
Table 61. In Silico Biosciences Personalized Therapy Biosimulation Platform Product and Services
Table 62. In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. In Silico Biosciences Recent Developments/Updates
Table 64. In Silico Biosciences Competitive Strengths & Weaknesses
Table 65. Genedata Basic Information, Area Served and Competitors
Table 66. Genedata Major Business
Table 67. Genedata Personalized Therapy Biosimulation Platform Product and Services
Table 68. Genedata Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Genedata Recent Developments/Updates
Table 70. Genedata Competitive Strengths & Weaknesses
Table 71. Physiomics Basic Information, Area Served and Competitors
Table 72. Physiomics Major Business
Table 73. Physiomics Personalized Therapy Biosimulation Platform Product and Services
Table 74. Physiomics Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Physiomics Recent Developments/Updates
Table 76. Physiomics Competitive Strengths & Weaknesses
Table 77. Insilico Biotechology Basic Information, Area Served and Competitors
Table 78. Insilico Biotechology Major Business
Table 79. Insilico Biotechology Personalized Therapy Biosimulation Platform Product and Services
Table 80. Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Insilico Biotechology Recent Developments/Updates
Table 82. Insilico Biotechology Competitive Strengths & Weaknesses
Table 83. Chemical Computing Group ULC(CCG) Basic Information, Area Served and Competitors
Table 84. Chemical Computing Group ULC(CCG) Major Business
Table 85. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product and Services
Table 86. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Chemical Computing Group ULC(CCG) Recent Developments/Updates
Table 88. Chemical Computing Group ULC(CCG) Competitive Strengths & Weaknesses
Table 89. Evidera Basic Information, Area Served and Competitors
Table 90. Evidera Major Business
Table 91. Evidera Personalized Therapy Biosimulation Platform Product and Services
Table 92. Evidera Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Evidera Recent Developments/Updates
Table 94. Evidera Competitive Strengths & Weaknesses
Table 95. AnyLogic Basic Information, Area Served and Competitors
Table 96. AnyLogic Major Business
Table 97. AnyLogic Personalized Therapy Biosimulation Platform Product and Services
Table 98. AnyLogic Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AnyLogic Recent Developments/Updates
Table 100. Shanghai Lide Basic Information, Area Served and Competitors
Table 101. Shanghai Lide Major Business
Table 102. Shanghai Lide Personalized Therapy Biosimulation Platform Product and Services
Table 103. Shanghai Lide Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Personalized Therapy Biosimulation Platform Upstream (Raw Materials)
Table 105. Personalized Therapy Biosimulation Platform Typical Customers
Table 1. World Personalized Therapy Biosimulation Platform Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Personalized Therapy Biosimulation Platform Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Personalized Therapy Biosimulation Platform Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Personalized Therapy Biosimulation Platform Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Personalized Therapy Biosimulation Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Personalized Therapy Biosimulation Platform Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Personalized Therapy Biosimulation Platform Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Personalized Therapy Biosimulation Platform Players in 2022
Table 12. World Personalized Therapy Biosimulation Platform Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Personalized Therapy Biosimulation Platform Company Evaluation Quadrant
Table 14. Head Office of Key Personalized Therapy Biosimulation Platform Player
Table 15. Personalized Therapy Biosimulation Platform Market: Company Product Type Footprint
Table 16. Personalized Therapy Biosimulation Platform Market: Company Product Application Footprint
Table 17. Personalized Therapy Biosimulation Platform Mergers & Acquisitions Activity
Table 18. United States VS China Personalized Therapy Biosimulation Platform Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Personalized Therapy Biosimulation Platform Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Personalized Therapy Biosimulation Platform Revenue Market Share (2018-2023)
Table 23. China Based Personalized Therapy Biosimulation Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Personalized Therapy Biosimulation Platform Revenue Market Share (2018-2023)
Table 26. Rest of World Based Personalized Therapy Biosimulation Platform Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Personalized Therapy Biosimulation Platform Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Personalized Therapy Biosimulation Platform Revenue Market Share (2018-2023)
Table 29. World Personalized Therapy Biosimulation Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Personalized Therapy Biosimulation Platform Market Size by Type (2018-2023) & (USD Million)
Table 31. World Personalized Therapy Biosimulation Platform Market Size by Type (2024-2029) & (USD Million)
Table 32. World Personalized Therapy Biosimulation Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Personalized Therapy Biosimulation Platform Market Size by Application (2018-2023) & (USD Million)
Table 34. World Personalized Therapy Biosimulation Platform Market Size by Application (2024-2029) & (USD Million)
Table 35. Cellworks Group Basic Information, Area Served and Competitors
Table 36. Cellworks Group Major Business
Table 37. Cellworks Group Personalized Therapy Biosimulation Platform Product and Services
Table 38. Cellworks Group Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Cellworks Group Recent Developments/Updates
Table 40. Cellworks Group Competitive Strengths & Weaknesses
Table 41. Certara Basic Information, Area Served and Competitors
Table 42. Certara Major Business
Table 43. Certara Personalized Therapy Biosimulation Platform Product and Services
Table 44. Certara Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Certara Recent Developments/Updates
Table 46. Certara Competitive Strengths & Weaknesses
Table 47. Simulation Plus Basic Information, Area Served and Competitors
Table 48. Simulation Plus Major Business
Table 49. Simulation Plus Personalized Therapy Biosimulation Platform Product and Services
Table 50. Simulation Plus Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Simulation Plus Recent Developments/Updates
Table 52. Simulation Plus Competitive Strengths & Weaknesses
Table 53. Schrodinger Basic Information, Area Served and Competitors
Table 54. Schrodinger Major Business
Table 55. Schrodinger Personalized Therapy Biosimulation Platform Product and Services
Table 56. Schrodinger Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Schrodinger Recent Developments/Updates
Table 58. Schrodinger Competitive Strengths & Weaknesses
Table 59. In Silico Biosciences Basic Information, Area Served and Competitors
Table 60. In Silico Biosciences Major Business
Table 61. In Silico Biosciences Personalized Therapy Biosimulation Platform Product and Services
Table 62. In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. In Silico Biosciences Recent Developments/Updates
Table 64. In Silico Biosciences Competitive Strengths & Weaknesses
Table 65. Genedata Basic Information, Area Served and Competitors
Table 66. Genedata Major Business
Table 67. Genedata Personalized Therapy Biosimulation Platform Product and Services
Table 68. Genedata Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Genedata Recent Developments/Updates
Table 70. Genedata Competitive Strengths & Weaknesses
Table 71. Physiomics Basic Information, Area Served and Competitors
Table 72. Physiomics Major Business
Table 73. Physiomics Personalized Therapy Biosimulation Platform Product and Services
Table 74. Physiomics Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Physiomics Recent Developments/Updates
Table 76. Physiomics Competitive Strengths & Weaknesses
Table 77. Insilico Biotechology Basic Information, Area Served and Competitors
Table 78. Insilico Biotechology Major Business
Table 79. Insilico Biotechology Personalized Therapy Biosimulation Platform Product and Services
Table 80. Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Insilico Biotechology Recent Developments/Updates
Table 82. Insilico Biotechology Competitive Strengths & Weaknesses
Table 83. Chemical Computing Group ULC(CCG) Basic Information, Area Served and Competitors
Table 84. Chemical Computing Group ULC(CCG) Major Business
Table 85. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product and Services
Table 86. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Chemical Computing Group ULC(CCG) Recent Developments/Updates
Table 88. Chemical Computing Group ULC(CCG) Competitive Strengths & Weaknesses
Table 89. Evidera Basic Information, Area Served and Competitors
Table 90. Evidera Major Business
Table 91. Evidera Personalized Therapy Biosimulation Platform Product and Services
Table 92. Evidera Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Evidera Recent Developments/Updates
Table 94. Evidera Competitive Strengths & Weaknesses
Table 95. AnyLogic Basic Information, Area Served and Competitors
Table 96. AnyLogic Major Business
Table 97. AnyLogic Personalized Therapy Biosimulation Platform Product and Services
Table 98. AnyLogic Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. AnyLogic Recent Developments/Updates
Table 100. Shanghai Lide Basic Information, Area Served and Competitors
Table 101. Shanghai Lide Major Business
Table 102. Shanghai Lide Personalized Therapy Biosimulation Platform Product and Services
Table 103. Shanghai Lide Personalized Therapy Biosimulation Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Personalized Therapy Biosimulation Platform Upstream (Raw Materials)
Table 105. Personalized Therapy Biosimulation Platform Typical Customers
LIST OF FIGURES
Figure 1. Personalized Therapy Biosimulation Platform Picture
Figure 2. World Personalized Therapy Biosimulation Platform Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Personalized Therapy Biosimulation Platform Total Market Size (2018-2029) & (USD Million)
Figure 4. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 13. Personalized Therapy Biosimulation Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. World Personalized Therapy Biosimulation Platform Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. China Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 23. India Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Personalized Therapy Biosimulation Platform by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Personalized Therapy Biosimulation Platform Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Personalized Therapy Biosimulation Platform Markets in 2022
Figure 27. United States VS China: Personalized Therapy Biosimulation Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Personalized Therapy Biosimulation Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Personalized Therapy Biosimulation Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Personalized Therapy Biosimulation Platform Market Size Market Share by Type in 2022
Figure 31. Pharmacokinetic
Figure 32. Pharmacoeconomics
Figure 33. World Personalized Therapy Biosimulation Platform Market Size Market Share by Type (2018-2029)
Figure 34. World Personalized Therapy Biosimulation Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Personalized Therapy Biosimulation Platform Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical and Biotech Companies
Figure 37. Research Institutions
Figure 38. Hospital
Figure 39. Others
Figure 40. Personalized Therapy Biosimulation Platform Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Personalized Therapy Biosimulation Platform Picture
Figure 2. World Personalized Therapy Biosimulation Platform Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Personalized Therapy Biosimulation Platform Total Market Size (2018-2029) & (USD Million)
Figure 4. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Personalized Therapy Biosimulation Platform Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Personalized Therapy Biosimulation Platform Revenue (2018-2029) & (USD Million)
Figure 13. Personalized Therapy Biosimulation Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. World Personalized Therapy Biosimulation Platform Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. China Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 23. India Personalized Therapy Biosimulation Platform Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Personalized Therapy Biosimulation Platform by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Personalized Therapy Biosimulation Platform Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Personalized Therapy Biosimulation Platform Markets in 2022
Figure 27. United States VS China: Personalized Therapy Biosimulation Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Personalized Therapy Biosimulation Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Personalized Therapy Biosimulation Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Personalized Therapy Biosimulation Platform Market Size Market Share by Type in 2022
Figure 31. Pharmacokinetic
Figure 32. Pharmacoeconomics
Figure 33. World Personalized Therapy Biosimulation Platform Market Size Market Share by Type (2018-2029)
Figure 34. World Personalized Therapy Biosimulation Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Personalized Therapy Biosimulation Platform Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical and Biotech Companies
Figure 37. Research Institutions
Figure 38. Hospital
Figure 39. Others
Figure 40. Personalized Therapy Biosimulation Platform Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
